Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Aparna Ramasubramanian MD

Aparna Ramasubramanian MD

Director, Retinoblastoma Program, Children's Wisconsin, Milwaukee, Wisconsin

Dr. Aparna Ramasubramanian is the Medical Director of Children’s Wisconsin retinoblastoma program. An expert in the field of ocular oncology in the United States, Dr. Ramasubramanian has very unique training as a dual fellowship–trained physician in both pediatric ophthalmology and ocular oncology.

Dr. Ramasubramanian is the author of the leading textbook on retinoblastoma and has published extensively in peer-reviewed journals. She received the American Academy of Ophthalmology Achievement Award in 2018 and the Knights Templar Research Award for her research in retinoblastoma.

Recent Contributions to PracticeUpdate:

  1. Multidisciplinary Management of Uveal Melanoma
  2. Safety and Efficacy of Nonconfluent Diode Laser Panretinal Photocoagulation for Retinopathy of Prematurity After Intravitreal Bevacizumab
  3. Multidisciplinary Management of Retinoblastoma: Approach to Treatment.
  4. Retinal Vasculitis Is Common in Idiopathic Pediatric Uveitis
  5. Multidisciplinary Management of Retinoblastoma: Diagnosis
  6. Pediatric Eye Injuries by Hydroalcoholic Gel During the COVID-19 Pandemic
  7. Factors Other Than Travel Burden Impact the Clinical Presentation of Retinoblastoma in Africa
  8. 2020 Top Stories in Eye Care: Low-Concentration Atropine for Myopia Progression (LAMP) Study
  9. Neurodevelopmental Outcomes After Bevacizumab Treatment for Retinopathy of Prematurity
  10. Self-Perception in Preschool Children With Deprivation Amblyopia

Most Read This Week

Recently Updated